Identifying potential targets for preventing cancer progression through the PLA2G1B recombinant protein using bioinformatics and machine learning methods.

Journal: International journal of biological macromolecules
PMID:

Abstract

Lung cancer is the deadliest and most aggressive malignancy in the world. Preventing cancer is crucial. Therefore, the new molecular targets have laid the foundation for molecular diagnosis and targeted therapy of lung cancer. PLA2G1B plays a key role in lipid metabolism and inflammation. PLA2G1B has selective substrate specificity. In this paper, the recombinant protein molecular structure of PLA2G1B was studied and novel therapeutic interventions were designed to disrupt PLA2G1B activity and impede tumor growth by targeting specific regions or residues in its structure. Construct protein-protein interaction networks and core genes using R's "STRING" program. LASSO, SVM-RFE and RF algorithms identified important genes associated with lung cancer. 282 deg were identified. Enrichment analysis showed that these genes were mainly related to adhesion and neuroactive ligand-receptor interaction pathways. PLA2G1B was subsequently identified as developing a preventative feature. GSEA showed that PLA2G1B is closely related to α-linolenic acid metabolism. Through the analysis of LASSO, SVM-RFE and RF algorithms, we found that PLA2G1B gene may be a preventive gene for lung cancer.

Authors

  • Shuhong Guan
    Department of Respiratory and Critical Care Medicine, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou 213000, China.
  • Zhanzhan Xu
    Soochow University, Suzhou 215031, China.
  • Tingting Yang
    School of Life Sciences, Nanjing University, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing 210000, China.
  • Yilei Zhang
    Soochow University, Suzhou 215031, China.
  • Yulin Zheng
    Soochow University, Suzhou 215031, China.
  • Tianyu Chen
    School of Mechanical and Aerospace Engineering, Nanyang Technological University, Singapore, 639798, Singapore.
  • Huimin Liu
    Department of Cardiology, The Key Laboratory of Myocardial Ischemia Chinese Ministry of Education Harbin, the Second Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, Nangang District, Harbin, 150086, People's Republic of China.
  • Jun Zhou
    Department of Clinical Research Center, Dazhou Central Hospital, Dazhou 635000, China.